WASHINGTON (Reuters) - U.S. health regulators are asking for advice on whether, and when, heart safety studies should be required for new obesity drugs, possibly adding a new hurdle on their path to approval. An advisory panel to the U.S. Food and Drug Administration will discuss this week whether regulators should mandate such trials before the drugs can be marketed in the United States. ...
Source: http://news.yahoo.com/u-ponders-heart-safety-trials-obesity-drugs-211552348.html
Love Interruption American Daydream Am I a Psycho? Beekeepers Daughter
Tidak ada komentar:
Posting Komentar